Question 1

What does Apeiron Therapeutics Inc do in rare disease treatment?

Accepted Answer

Apeiron Therapeutics (also known as GT Apeiron) is a clinical-stage biopharmaceutical company developing biomarker-driven cancer therapeutics using AI-guided drug design. The company's lead program GTA182 targets MTAP-deleted cancers and presented first-in-human Phase 1 data in December 2025. Note: this is a separate entity from Apeiron Biologics (Austrian, acquired by Ligand Pharmaceuticals), which developed dinutuximab beta for neuroblastoma.

Question 2

Does Apeiron Therapeutics Inc have a rare disease division?

Accepted Answer

Apeiron Therapeutics Inc is a diversified pharmaceutical company headquartered in San Francisco Bay Area, United States, founded in 2018. While it operates across multiple therapeutic areas, it maintains a significant rare disease portfolio with 0 active rare disease programs. Many of its rare disease treatments hold orphan drug designations from the FDA.

Question 3

How can I find Apeiron Therapeutics Inc clinical trials for rare diseases?

Accepted Answer

This page shows all active and recruiting clinical trials sponsored by Apeiron Therapeutics Inc, pulled live from ClinicalTrials.gov. Each trial card includes the study phase, recruitment status, conditions being studied, number of trial sites, and a direct link to the full study record. You can also explore individual disease pages to see trials from all sponsors for a specific condition.

Question 4

How do I enroll in an Apeiron Therapeutics Inc clinical trial?

Accepted Answer

To explore enrollment, find a recruiting trial on this page and click "View full study" to see the full ClinicalTrials.gov record, which includes eligibility criteria, study locations, and contact information for each trial site. Your doctor can also help determine if a specific trial is appropriate for your condition. Not all trials are open at every location, so check the site list for one near you.

Question 5

What FDA-approved rare disease drugs does Apeiron Therapeutics Inc have?

Accepted Answer

The FDA-Approved Drugs section on this page lists all Apeiron Therapeutics Inc drugs with FDA approval that are relevant to rare diseases, including brand names, generic names, approval dates, and the rare conditions each drug treats. This data comes from the FDA's openFDA database and is updated automatically.

Question 6

When was Apeiron Therapeutics Inc founded and where is it based?

Accepted Answer

Apeiron Therapeutics Inc was founded in 2018 and is headquartered in San Francisco Bay Area, United States. The company has been active for 8 years.

Apeiron Therapeutics Inc

Focus areas at Apeiron Therapeutics Inc

Active Clinical Trials

FDA-Approved Drugs

Frequently Asked Questions About Apeiron Therapeutics Inc